Drug Coverage

Latest News

leesle-stock.adobe.com
Sandoz Launches Biosimilars of Xgeva/Prolia

June 17th 2025

Wyost and Jubbonti are interchangeable with Xgeva/Prolia and are approved for all of the same indications in bone cancer and osteoporosis.

Biosimilar Uptake Has Been Slow but This is Changing
Biosimilar Uptake Has Been Slow but This is Changing

June 13th 2025

Blue Shield of California Breaks Up Pharmacy Benefit; Other Payers Considering the Same Approach
Blue Shield of California Breaks Up Pharmacy Benefit; Other Payers Considering the Same Approach

June 10th 2025

Requiring Humira Biosimilars Results in Huge Savings for Navitus Clients
Requiring Humira Biosimilars Results in Huge Savings for Navitus Clients

June 10th 2025

ckybe-stock.adobe.com
Transparency for PBMs. Can It Become Something More than Just a Buzzword?

June 6th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.